Ajit Sharan serves as an Independent Director at Dabur India Ltd. He has been involved with the company since at least January 2021.
His role contributes to the governance and strategic oversight of the company, which is known for its strong brand presence and leadership in the FMCG sector, particularly in Ayurveda and natural healthcare.
His experience and insights are valuable for Dabur as it continues to expand its market presence and innovate within its product offerings.
Ajit Sharan is serving the company - Dabur India Ltd at this position since 2023 for the last 2+ years.
Prior to becoming Independent Director, Ajit Sharan was Independent Director of Capri Global Capital Ltd for 6 years from 2019 to 2024.
Before becoming Independent Director, Ajit Sharan was Independent Non Exe.
FAQ's related Ajit Sharan
Who is Ajit Sharan
Ajit Sharan serves as an Independent Director at Dabur India Ltd. He has been involved with the company since at least January 2021. His role contributes to the governance and strategic oversight of the company, which is known for its strong brand presence and leadership in the FMCG sector, particularly in Ayurveda and natural healthcare. His experience and insights are valuable for Dabur as it continues to expand its market presence and innovate within its product offerings.
Which companies does Ajit Sharan serve as a board member for?
Ajit Sharan serves as a board member for: Oriental Infra Trust,Capri Global Capital Ltd,Dabur India Ltd
What positions has Ajit Sharan held in his/her career?
Throughout their career, Ajit Sharan has held key positions such as Independent Director,Independent Non Exe. Director,Non-Exec. & Independent Dir.,Addtnl Independent Director, contributing to the growth and success of each company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.